is semaglutide addictive GLP-1 drugs protect against new or worsening addictions, large study shows Scientists Discover Amazing New Benefit
Description
Game-changing oral drug has similar success rate to injections with potentially serious side-effects

Boehringer Ingelheim and Gubra initiate Phase 1 trials for BI 3034701, a novel triple-agonist peptide drug candidate for obesity.

Find out the answer and all about the history of semaglutide (including Ozempic and Wegovy).
Wegovy or Zepbound compared : differences, weight loss results, side effects, and which drug suits your health goals best.
Check if you qualify for GLP-1 weight loss medication (semaglutide & tirzepatide)

This comparison is not as simple as 'tirzepatide wins, use tirzepatide.' The full picture is more nuanced.
